Oxygenta Pharmaceutical Ltd — Updates, 14-08-2025: Company Update

Oxygenta Pharmaceutical Limited has announced a board meeting where it reviewed the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs 15.13 Cr, an increase from Rs 12.62 Cr in the prior year's corresponding quarter. However, the net loss for the quarter significantly widened to Rs 6.11 Cr, compared to a loss of Rs 1.36 Cr in the same period last year. Additionally, the company appointed new Internal, Secretarial, and Cost Auditors for the upcoming financial year, and appointed a new Company Secretary and Compliance Officer following a resignation.